GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » Payments of Debt

Marrone Bio Innovations (Marrone Bio Innovations) Payments of Debt : $-41.19 Mil (TTM As of Mar. 2022)


View and export this data going back to 2013. Start your Free Trial

What is Marrone Bio Innovations Payments of Debt?

Marrone Bio Innovations's Payments of Debt for the three months ended in Mar. 2022 was $-12.16 Mil.

Marrone Bio Innovations's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2022 was $-41.19 Mil.

Marrone Bio Innovations Payments of Debt Historical Data

The historical data trend for Marrone Bio Innovations's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marrone Bio Innovations Payments of Debt Chart

Marrone Bio Innovations Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.13 -21.30 -29.54 -35.31 -37.85

Marrone Bio Innovations Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.82 -12.00 -10.10 -6.93 -12.16

Marrone Bio Innovations Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-41.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marrone Bio Innovations Payments of Debt Related Terms

Thank you for viewing the detailed overview of Marrone Bio Innovations's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Marrone Bio Innovations (Marrone Bio Innovations) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » Payments of Debt
Comparable Companies
CGA SEED RKDA YTEN SVFD KNGW BIOX BHIL AVD IPI TSX:NTR CTVA SZSE:000792 MOS CF SAU:2020 MIC:PHOR FMC XTAE:ICL OSL:YAR
Traded in Other Exchanges
N/A
Address
7780-420 Brier Creek Parkway,, Raleigh, NC, USA, 27617
Website
https://www.marronebioinnovations.com
Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.
Executives
Pamela G Marrone director, officer: CEO and President C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, A-107, DAVIS CA 95618
Ladon Johnson officer: Interim CFO C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARWAY RALEIGH NC 27617-7882
Ardsley Ridgecrest Partners Fund, L.p. other: See Footnote (1) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Suping (sue) Cheung officer: Chief Financial Officer C/O QUICKLOGIC CORPORATION, SUNNYVALE CA 94089
Matti Tiainen officer: SVP, International Sales C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Lara L Lee director C/O MARRONE BIO INNOVATIONS, INC., 1540 DREW AVENUE, DAVIS CA 95618
Kevin Helash director, officer: Chief Executive Officer C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Ardsley Advisory Partners Gp Llc other: See Footnotes(1)(2) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Ospraie Management, Llc director, 10 percent owner, other: (See Remarks) 437 MADISON AVENUE, 28TH FLOOR, NEW YORK NY 10022
Ospraie Management, Inc. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ospraie Holding I, L.p. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Dwight Anderson director, 10 percent owner, other: (See Remarks) C/O OSPRAIE MANAGEMENT, LLC, 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ardsley Healthcare Fund, L.p. other: See Footnote (1) C/O ARDSLEY PARTNERS I GP, LLC, 262 HARBOR DRIVE, STAMFORD CT 06902
Ospraie Ag Science Llc director, 10 percent owner, other: (See Remarks) C/O DWIGHT ANDERSON 437 MADISON AVENUE, 28TH FLOOR NEW YORK NY 10022
Van Herk Investments B.v. 10 percent owner LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME